Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy

Science
B A LarderP R Harrigan

Abstract

Combinations of antiretroviral drugs that prevent or delay the appearance of drug-resistant human immunodeficiency virus-type 1 (HIV-1) mutants are urgently required. Mutants resistant to 3'-azidothymidine (AZT, zidovudine) became phenotypically sensitive in vitro by mutation of residue 184 of viral reverse transcriptase to valine, which also induced resistance to (-)2'-deoxy-3'-thiacytidine (3TC). Furthermore, AZT-3TC coresistance was not observed during extensive in vitro selection with both drugs. In vivo AZT-3TC combination therapy resulted in a markedly greater decreased in serum HIV-1 RNA concentrations than treatment with AZT alone, even though valine-184 mutants rapidly emerged. Most samples assessed from the combination group remained AZT sensitive at 24 weeks of therapy, consistent with in vitro mutation studies.

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·P KellamB A Larder
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·J P VartanianS Wain-Hobson
Apr 1, 1993·Antimicrobial Agents and Chemotherapy·R F SchinaziJ W Mellors
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M TisdaleB A Larder
Jun 1, 1993·Antimicrobial Agents and Chemotherapy·D D Richman

❮ Previous
Next ❯

Citations

Dec 1, 1996·Reviews in Medical Virology·W G Rice, J A Turpin
Jan 13, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S A Locarnini
Feb 14, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M MelegariJ R Wands
Jun 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M I AllenL D Condreay
Jan 1, 1997·Springer Seminars in Immunopathology·D V Havlir, D D Richman
Jul 13, 2006·Archives of Pharmacal Research·Rafik SamuelByungse Suh
Nov 30, 2000·Current Infectious Disease Reports·G J Hanna, R T D'Aquila
Feb 1, 1996·Trends in Microbiology·D M Coen
Jun 16, 2004·Antiviral Research·Youhoon Chong, Chung K Chu
Mar 28, 2002·Mathematical Biosciences·Davide Verotta, Franziska Schaedeli
Sep 21, 1996·Lancet·J J Lipsky
May 1, 1997·The Journal of Infection·A M Lever
Oct 6, 2001·Journal of Chromatography. B, Biomedical Sciences and Applications·J J ZhengT A Emm
Jan 1, 1997·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·G Mathé
May 25, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·P BonfantiG Rizzardini
Jan 6, 2001·Infectious Disease Clinics of North America·N A Kartsonis, R T D'Aquila
May 1, 2001·Bioorganic & Medicinal Chemistry Letters·J WirschingE De Clercq
Apr 21, 1999·Trends in Microbiology·P R Harrigan, C S Alexander
Jun 9, 2001·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·J G García-Lerma, W Heneine
Jun 22, 2001·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·M Arens
Feb 3, 2005·Nature Reviews. Drug Discovery·Curtis T KeithBrent R Stockwell
Feb 24, 2007·Nature Reviews. Drug Discovery·Hiroaki Kitano
Jan 31, 2009·Nature Reviews. Drug Discovery·Jia JiaYu Zong Chen
Jan 22, 2003·Journal of Gastroenterology and Hepatology·Robert Y M ChenStephen A Locarnini
Dec 12, 2001·HIV Medicine·UNKNOWN BHIVA Writing Committee, UNKNOWN BHIVA Executive Committee
Dec 12, 2001·HIV Medicine·G Moyle
Dec 21, 1995·The New England Journal of Medicine·T C Merigan
Mar 5, 2004·The New England Journal of Medicine·François Clavel, Allan J Hance
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·P J TumminoD Hupe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.